微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 55.8% | -7.87% | -3.76% | 65/139 | 51.97% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-12-31 | 57.97% | -1.28% | -1.89% | 61/139 | 51.43% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-09-30 | 59.09% | 0.51% | -1.68% | 59/139 | 51.66% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-06-30 | 60.1% | 1.69% | -0.77% | 59/139 | 51.8% | 佰仁医疗 | 88.54% | 行业排名> |
| 2025-03-31 | 60.56% | 0.03% | 3.13% | 52/139 | 51.48% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 58.73% | -7.53% | -0.11% | 59/139 | 52.35% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 58.79% | -10.31% | -0.52% | 59/139 | 53.23% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 59.1% | -12.63% | -2.39% | 59/139 | 53.35% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 60.54% | -11.39% | -4.67% | 52/139 | 53.36% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 63.51% | -8.09% | -3.11% | 50/139 | 53.18% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 65.55% | -7.12% | -3.09% | 40/139 | 54.03% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 67.64% | -3.16% | -1% | 34/139 | 53.47% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 68.33% | 2% | -1.13% | 33/139 | 53.71% | 正海生物 | 89.78% | 行业排名> |
| 2022-12-31 | 69.11% | -4.59% | -2.09% | 29/139 | 53.71% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 70.58% | 2% | 1.05% | 26/139 | 55.18% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 69.84% | 0.59% | -3.57% | 28/139 | 54.84% | 三友医疗 | 90.29% | 行业排名> |
| 2021-12-31 | 72.43% | -0.25% | -0.25% | 28/139 | 57.28% | 三友医疗 | 90.73% | 行业排名> |
| 2020-12-31 | 72.61% | 6.68% | 6.68% | 34/139 | 59.49% | 三友医疗 | 90.5% | 行业排名> |
| 2019-12-31 | 68.06% | 2.66% | 2.66% | 39/139 | 56.29% | 三友医疗 | 90.29% | 行业排名> |
| 2018-12-31 | 66.29% | 3.35% | -4.52% | 42/139 | 55.53% | 正海生物 | 90.78% | 行业排名> |
| 2018-06-30 | 69.44% | 10.98% | 8.24% | 15/139 | 51.82% | 正海生物 | 91.59% | 行业排名> |
| 2017-12-31 | 64.15% | 2% | 2.53% | 42/139 | 55.55% | 正海生物 | 92.23% | 行业排名> |
| 2017-06-30 | 62.57% | 2% | 2% | 25/139 | 54.31% | 正海生物 | 92.69% | 行业排名> |